Critical illness-related bone loss is associated with osteoclastic and angiogenic abnormalities

Journal of Bone and Mineral Research

Volumn 27, Issue 7, 2012, Pages 1541-1552

  Owen, Helen C ^a   Vanhees, Ineke ^a   Solie, Lien ^a   Roberts, Scott J ^b   Wauters, Andy ^a   Luyten, Frank P ^b   Van Cromphaut, Sophie ^a   Van Den Berghe, Greet ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Critical illness; FcR III; Human periosteal derived cells; Osteoclasts; Peripheral blood mononuclear cells

Indexed keywords

CALCIUM PHOSPHATE; CD11B ANTIGEN; CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; FC RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G ANTIBODY; VASCULOTROPIN RECEPTOR 1;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE METABOLISM; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FRACTURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PERIOSTEUM; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BONE AND BONES; BONE DISEASES; CRITICAL ILLNESS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OSTEOCLASTS; OSTEOGENESIS; PERIOSTEUM; RECEPTORS, IGG;

EID: 84862504482     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1612     Document Type: Article

References (28)

1. Derde S VI, Guiza F, Derese I, Gunst J, Fahrenkrog B, Martinet W, Vervenne H, Ververs EJ, Larsson L, Van den Berghe G. Early parenteral nutrition evokes a phenotype of autophagy-deficiency in liver and skeletal muscle of critically ill rabbits. Endocrinology. Epub 2012 Mar 6.
2. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003;88(10):4623-32. (Pubitemid 37357503)
3. Orford NR, Saunders K, Merriman E, Henry M, Pasco J, Stow P, Kotowicz M. Skeletal morbidity among survivors of critical illness. Crit Care Med. 2011 Jun; 39(6):1295-300.
4. D'Amelio P, Grimaldi A, Pescarmona GP, Tamone C, Roato I, Isaia G. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis. FASEB J. 2005;19(3):410-2. (Pubitemid 40316533)
5. Neale SD, Schulze E, Smith R, Athanasou NA. The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease. QJM. 2002;95(4):233-40. (Pubitemid 34413730)
6. Shead EF, Haworth CS, Barker H, Bilton D, Compston JE. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J Cyst Fibros. 2010 Mar; 9(2):93-8.
7. Chiu YG, Shao T, Feng C, Mensah KA, Thullen M, Schwarz EM, Ritchlin CT. CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther. 2011;12(1):R14.
8. Roberts SJ, Geris L, Kerckhofs G, Desmet E, Schrooten J, Luyten FP. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials. 2011;32(19):4393-405.
9. Roato I, Porta F, Mussa A, D'Amico L, Fiore L, Garelli D, Spada M, Ferracini R. Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase. PLoS One. 2011;5(11):e14167.
10. D'Amelio P, Cristofaro MA, Grimaldi A, Ravazzoli M, Pluviano F, Grosso E, Pescarmona GP, Isaia GC. The role of circulating bone cell precursors in fracture healing. Calcif Tissue Int. 2011;86(6):463-9.
11. Massey HM, Scopes J, Horton MA, Flanagan AM. Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. Bone. 2001;28(6):577-82. (Pubitemid 32577374)
12. Ariyoshi W, Takahashi T, Kanno T, Ichimiya H, Shinmyouzu K, Takano H, Koseki T, Nishihara T. Heparin inhibits osteoclastic differentiation and function. J Cell Biochem. 2008;103(6):1707-17. (Pubitemid 351501904)
13. Roberts SJ, Chen Y, Moesen M, Schrooten J, Luyten FP. Enhancement of osteogenic gene expression for the differentiation of human periosteal derived cells. Stem Cell Res. 2011;7(2):137-44.
14. Chai YC, Roberts SJ, Schrooten J, Luyten FP. Probing the osteoinductive effect of calcium phosphate by using an in vitro biomimetic model. Tissue Eng Part A. 2011;17(7-8):1083-97.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8. (Pubitemid 34164012)
16. Roato I, Grano M, Brunetti G, Colucci S, Mussa A, Bertetto O, Ferracini R. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement. FASEB J. 2005;19(2):228-30. (Pubitemid 40189264)
17. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan IM, Archer CW, Jones EA, McGonagle D, Mitsiadis TA, Pitzalis C, Luyten FP. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum. 2006;54(4):1209-21. (Pubitemid 43672933)
18. De Bari C, Dell'Accio F, Luyten FP. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum. 2001;44(1):85-95. (Pubitemid 32113122)
19. Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiore CE. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab. 2010;95(5):2248-53.
20. Nose M, Yamazaki H, Hagino H, Morio Y, Hayashi S, Teshima R. Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients. J Bone Miner Metab. 2009;27(1):57-65.
21. Olivier BJ, Schoenmaker T, Mebius RE, Everts V, Mulder CJ, van Nieuwkerk KM, de Vries TJ, van der Merwe SW. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia. Hepatology. 2008;47(1):259-67. (Pubitemid 351171063)
22. D'Amelio P, Roato I, D'Amico L, Veneziano L, Suman E, Sassi F, Bisignano G, Ferracini R, Gargiulo G, Castoldi F, Pescarmona GP, Isaia GC. Bone and bone marrow pro-osteoclastogenic cytokines are upregulated in osteoporosis fragility fractures. Osteoporos Int. 2012 Apr; 23(4):1245-53.
23. Roato I, D'Amelio P, Gorassini E, Grimaldi A, Bonello L, Fiori C, Delsedime L, Tizzani A, De Libero A, Isaia G, Ferracini R. Osteoclasts are active in bone forming metastases of prostate cancer patients. PLoS One. 2008;3(11):e3627.
24. Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, O'Keefe RJ, Xing L. TNF-alpha and pathologic bone resorption. Keio J Med. 2005;54(3):127-31.
25. Szalay F, Hegedus D, Lakatos PL, Tornai I, Bajnok E, Dunkel K, Lakatos P. High serum osteoprotegerin and low RANKL in primary biliary cirrhosis. J Hepatol. 2003;38(4):395-400. (Pubitemid 36399239)
26. Fedak PW, Kasatkin A. Enhancing sternal closure using Kryptonite bone adhesive: technical report. Surg Innov. 2011 Dec; 18(4):NP8-11.
27. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res. 2009;24(2):274-82.
28. Caparbo VF, Prada F, Silva CA, Regio PL, Pereira RM. Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts "in vitro". Clin Rheumatol. 2009;28(1):71-7.